DCF 987: Phase II

In a double-blind, Canadian Phase II trial in 60 patients, 1000 mg DCF 987-treated patients had a mean FEV1 improvement of 2.55%, 500 mg DCF 987 patients had a 0.55% improvement, and placebo patients ...